These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 9782579

  • 1. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A.
    Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ, Sandborn WJ, Tremaine WJ.
    Am J Gastroenterol; 1998 Mar 04; 93(3):442-8. PubMed ID: 9517654
    [Abstract] [Full Text] [Related]

  • 3. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 04; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 4. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.
    Hermida-Rodriguez C, Cantero Perona J, Garcia-Valriberas R, Pajares Garcia JM, Mate-Jimenez J.
    Hepatogastroenterology; 1999 Oct 04; 46(28):2265-8. PubMed ID: 10521978
    [Abstract] [Full Text] [Related]

  • 5. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 01; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 7. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Compr Ther; 1985 Dec 01; 11(12):14-9. PubMed ID: 2866866
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine for severe ulcerative colitis.
    Pham CQ, Efros CB, Berardi RR.
    Ann Pharmacother; 2006 Jan 01; 40(1):96-101. PubMed ID: 16368919
    [Abstract] [Full Text] [Related]

  • 9. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA, Petritsch W, Aichbichler B, Fickert P, Ranner G, Krejs GJ.
    Z Gastroenterol; 1997 Aug 01; 35(8):603-8. PubMed ID: 9297775
    [Abstract] [Full Text] [Related]

  • 10. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
    Wenzl HH, Petritsch W, Aichbichler BW, Hinterleitner TA, Fleischmann G, Krejs GJ.
    Z Gastroenterol; 1998 Apr 01; 36(4):287-93. PubMed ID: 9612926
    [Abstract] [Full Text] [Related]

  • 11. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.
    Fernández-Bañares F, Bertrán X, Esteve-Comas M, Cabré E, Menacho M, Humbert P, Planas R, Gassull MA.
    Am J Gastroenterol; 1996 Dec 01; 91(12):2498-9. PubMed ID: 8946973
    [Abstract] [Full Text] [Related]

  • 12. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E, Beau P.
    Gastroenterol Clin Biol; 2002 Apr 01; 26(4):367-71. PubMed ID: 12070412
    [Abstract] [Full Text] [Related]

  • 13. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
    Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA.
    Am J Gastroenterol; 2008 May 01; 103(5):1203-9. PubMed ID: 18422816
    [Abstract] [Full Text] [Related]

  • 14. Intravenous cyclosporine for inflammatory bowel disease--safe and effective.
    Chermesh I, Tamir A, Lachter J, Eliakim R.
    Hepatogastroenterology; 2007 May 01; 54(79):2003-6. PubMed ID: 18251148
    [Abstract] [Full Text] [Related]

  • 15. [Drug treatment of Crohn's disease].
    van Deventer SJ, Tytgat GN.
    Ned Tijdschr Geneeskd; 1998 May 23; 142(21):1191-5. PubMed ID: 9627451
    [Abstract] [Full Text] [Related]

  • 16. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 23; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis.
    Miyake N, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, Maeda K, Morise K, Matsushita M, Furukawa K, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H.
    World J Gastroenterol; 2015 Jan 07; 21(1):254-61. PubMed ID: 25574099
    [Abstract] [Full Text] [Related]

  • 18. Intravenous azathioprine in severe ulcerative colitis: a pilot study.
    Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ.
    Am J Gastroenterol; 2000 Dec 07; 95(12):3463-8. PubMed ID: 11151878
    [Abstract] [Full Text] [Related]

  • 19. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis.
    Levine DS, Fischer SH, Christie DL, Haggitt RC, Ochs HD.
    Am J Gastroenterol; 1992 Jan 07; 87(1):91-100. PubMed ID: 1728132
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU.
    Am J Gastroenterol; 2006 May 07; 101(5):1048-56. PubMed ID: 16573777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.